Sanofi and MD Anderson announce strategic collaboration to accelerate oncology research and development Read more
Fate Therapeutics Announces Exclusive License Agreement with Baylor College of Medicine for Rejection-resistant iPSC-derived Cellular Therapies Read more
Roche collaborates with Blueprint Medicines to bring a new treatment to people with RET-altered cancers Read more
TREMFYA Approved by FDA as the First Selective Interleukin (IL)-23 Inhibitor for Active Psoriatic Arthritis Read more
Glenmark Commences 1000 Patients Post Marketing Surveillance Study With COVID-19 Who Are Administered FabiFlu Read more
Rocket Pharma Announces First Patient Treated in Phase 1 Trial of RP-L301 Gene Therapy for Pyruvate Kinase Deficiency Read more